Cargando…
Botanicals in Postmenopausal Osteoporosis
Osteoporosis is a systemic bone disease characterized by reduced bone mass and the deterioration of bone microarchitecture leading to bone fragility and an increased risk of fractures. Conventional anti-osteoporotic pharmaceutics are effective in the treatment and prophylaxis of osteoporosis, howeve...
Autores principales: | Słupski, Wojciech, Jawień, Paulina, Nowak, Beata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151026/ https://www.ncbi.nlm.nih.gov/pubmed/34064936 http://dx.doi.org/10.3390/nu13051609 |
Ejemplares similares
-
Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008) -
Treatment options for postmenopausal osteoporosis
por: Walsh, Garry M
Publicado: (2012) -
Adiponectin as a Biomarker of Osteoporosis in Postmenopausal Women: Controversies
por: Lubkowska, Anna, et al.
Publicado: (2014) -
Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006) -
Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)